Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors
Diagnostics · 22.07.2025 · 15 (15) · 1840
DOI: 10.3390/diagnostics15151840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 22.07.2025. Verfasst von Enis Mert Yorulmaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Izmir Katip Celebi University, Izmir 35620, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Upper tract urothelial carcinoma (UTUC) is often complicated by intravesical recurrence and cancer progression following radical nephroureterectomy (RNU). Identifying reliable prognostic biomarkers remains crucial for optimizing postoperative surveillance. The goal of this study was to assess the prognostic value of the De Ritis ratio (AST/ALT) in predicting bladder recurrence and oncologic outcomes in patients with clinically localized UTUC undergoing RNU.
Methods
This retrospective study analyzed 87 patients treated with RNU between 2018 and 2025. Preoperative De Ritis ratios were calculated, and an optimal cut-off value of 1.682 was determined using ROC analysis. Recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) were analyzed using the Kaplan–Meier and Cox regression methods. Logistic regression was used to identify independent predictors of bladder recurrence.
Results
A high De Ritis ratio was significantly associated with increased bladder recurrence and worse RFS and CSS, but not OS. Multivariate analysis confirmed that an elevated De Ritis ratio, current smoking, positive surgical margins, and synchronous bladder cancer were the independent predictors of bladder recurrence. The De Ritis ratio demonstrated strong discriminatory performance (AUC: 0.807), with good sensitivity and specificity for predicting recurrence.
Conclusions
The De Ritis ratio is a simple, cost-effective preoperative biomarker that may aid in identifying UTUC patients at higher risk for intravesical recurrence and cancer-specific mortality. Incorporating this ratio into clinical decision-making could enhance risk stratification and guide tailored follow-up strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Izmir Katip Celebi University, Izmir 35620, Turkey.
- Department of Urology, Ataturk Research and Training Hospital, Izmir 35360, Turkey.
ORCID-Profile: Enis Mert Yorulmaz, Serkan Ozcan, Yigit Akin
Zitieren
APA
Yorulmaz, E. M., Donmez, K., Ozcan, S., Kose, O., Gorgel, S. N., Candemir, E., & Akin, Y. (2025). Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors. Diagnostics, 15(15), 1840. https://doi.org/10.3390/diagnostics15151840
Vancouver
Yorulmaz EM, Donmez K, Ozcan S, Kose O, Gorgel SN, Candemir E, et al. Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors. Diagnostics. 2025;15(15):1840. doi:10.3390/diagnostics15151840
BibTeX
@article{Yorulmaz2025,
author = {Yorulmaz, Enis Mert and Donmez, Kursad and Ozcan, Serkan and Kose, Osman and Gorgel, Sacit Nuri and Candemir, Enes and Akin, Yigit},
title = {Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {15},
pages = {1840},
doi = {10.3390/diagnostics15151840}
}
EUVIMED